299
Entrada Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
210
FY23:
370
FY24:
440
FY25:
306
(positive)
Change from FY21 to FY25
millions USD
FY21:
7.13
FY22:
42.2
FY23:
99.4
FY24:
86.3
FY25:
71.1
Total assets
Change from FY21 to FY25
millions USD
FY21:
306
FY22:
252
FY23:
469
FY24:
526
FY25:
377
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.72
FY22:
22.0
FY23:
159
FY24:
39.5
FY25:
24.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.40
FY22:
17.5
FY23:
68.0
FY24:
58.2
FY25:
46.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
299
FY22:
213
FY23:
242
FY24:
429
FY25:
306
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
306
FY22:
252
FY23:
469
FY24:
526
FY25:
377
All amounts in millions USD